Organogenesis Holdings
ORGO
153 hedge funds and large institutions have $763M invested in Organogenesis Holdings in 2021 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 39 reducing their positions, and 20 closing their positions.
62% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 39
55% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 20
7% more funds holding
Funds holding: 143 → 153 (+10)
2.6% more ownership
Funds ownership: 38.96% → 41.55% (+2.6%)
8% less capital invested
Capital invested by funds: $830M → $763M (-$67.1M)
54% less call options, than puts
Call options by funds: $2.66M | Put options by funds: $5.83M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.2M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$19.2M |
| 3 |
BlackRock
New York
|
+$16.4M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$13.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$19.9M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$8.79M |
| 3 |
CCM
CAAS Capital Management
New York
|
-$7.86M |
| 4 |
Millennium Management
New York
|
-$7.68M |
| 5 |
Morgan Stanley
New York
|
-$6.57M |
ORGO Hedge Fund Activity: Q3 2021 in Review
153 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q3 2021, worth a combined $763M — down 8.1% from $830M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new ORGO positions and 20 closed out — a net gain of 11 holders — while 63 added to existing stakes and 39 trimmed.
The largest buyer was Vanguard Group, adding an estimated $21.2M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $19.9M sold.
- 153 institutional investors held Organogenesis Holdings (ORGO) as of Q3 2021, up from 143 in Q2 2021.
- Funds reported $763M of Organogenesis Holdings stock for Q3 2021, down 8.1% quarter-over-quarter.
- 31 funds opened new Organogenesis Holdings positions in Q3 2021 and 20 closed out, a net change of +11 holders.
- The largest Organogenesis Holdings buyer in Q3 2021 was Vanguard Group, an estimated $21.2M added.
- The largest Organogenesis Holdings seller in Q3 2021 was Pura Vida Investments, an estimated $19.9M sold.
Based on aggregated 13F filings for Q3 2021.